Skip to main content

Glycolipids and Glycoproteins in Plasma Membrane of Hepatocellular Cancer

  • Chapter
The Molecular Immunology of Complex Carbohydrates

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 228))

  • 151 Accesses

Abstract

The recent literature contains numerous studies of glycolipids and glycoproteins of tumor cells. Diverse changes in chemical composition and/or organization have been found in tumor cells of various sources: chemical and viral transformation in vitro and tumor tissues in vivo.1,2 They have incited wide interest although little is known about their exact biological significance. Theoretically, they may lead to an understanding of some essential problems, such as the malignant behavior of tumor cells and the role of gene mutation in the development of cancer. In addition, their practical potentialities as tumor markers has also been extensively explored.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. S. Hakomori. Monoclonal antibodies directed to cell-surface carbohydrates, in “Monoclonal antibodies and functional cell lines.” pp. 67–100. R.H. Kennet, K.B. Bechtol, and T.J. McKaarn ed., Plenum Publishing, New York. (1984).

    Google Scholar 

  2. R.F. Irie, L.L. Sze, and R.E. Saxton. Human antibody to OFA-1, a tumor antigen, produced in vitro by Epstein- Barr virus-transformed human B-lymphoid cell lines. Proc. Natl. Acad. Sci. USA 79:5666–5670, (1982).

    Article  PubMed  CAS  Google Scholar 

  3. Shun-zhang Yu. Epidemiology of primary liver cancer, in “Subclinical Hepatocellular Carcinoma,” Z.Y. Tang ed., pp. 189–211. China Academic Publishers, Beijing, Spring-Verlag, Berlin. (1985).

    Google Scholar 

  4. Zhao-you Tang. A new concept of the natural history of AFP positive hepatocellular carcinoma, in “Subclinical Hepatocellular Carcinoma,” Z.Y. Tang ed., pp. 171–177. China Academic Publishers, Beijing, Spring-Verlag, Berlin. (1985).

    Google Scholar 

  5. R.O. Brady, C. Borek, and R.M. Bradley. Composition and synthesis of gangliosi.de in rat hepatocyte and hepatoma cell lines. J. Biol. Chem. 244:6552–6554, (1969).

    PubMed  CAS  Google Scholar 

  6. S. Hakomori. Change of glycolipid pattern in Morris hepatoma 5123 and 7800. Cancer Research, 30:2930–2936, (1970).

    PubMed  CAS  Google Scholar 

  7. E.V. Dyatlovitskaya. Gangliosides of rat liver and hepatoma 27. Biochimya (Russ), 39: 552–556, (1974).

    CAS  Google Scholar 

  8. A.M. Dnistiran, V.P. Skipski, M. Barclay, and C.C. Stock. Alterations in glycosphingolipids of plasma membranes from Morris hepatoma 5132TC. Cancer Res., 37:2182–2187, (1977).

    Google Scholar 

  9. E.V. Dyalovitskaya, A.M. Novikov, N.P. Gorkova, and L.D. Bergelson. Gangliosides of hepatoma 27, normal and regenerating rat liver. Eur. J. Biochem., 67:357–364, (1976).

    Article  Google Scholar 

  10. R.P. Van Hoeven and P. Emmelot. Plasma membrane lipids of normal and neoplastic tissues, in “Tumor lipids: Biochemistry and Metabolism”, pp. 126–138. E. Wood ed., Amer. Oil Chemist’s Soc. Press: Illinois, (1973).

    Google Scholar 

  11. W.D. Merritt, C.L. Richardson, T.W. Keenan, and D.J. Morre. Gangliosides of liver tumors induced by N-2- fluorenylacetamide I. Ganglioside alterations in liver tumorigenesis and normal development. J. Nat’l. Cancer Inst., 60: 1313–1327, (1978).

    CAS  Google Scholar 

  12. W.D. Merritt, C.L. Richardson, T.W. Keenan, and D.J. Morre. Ganglioside of liver tumors induced by N-2- fluorenylacetamide II. Alterations in biosynthetic enzymes. J. Nat’l. Cancer Inst., 60: 1329–1337, (1978)

    CAS  Google Scholar 

  13. D.J. Morre, T.M. Kloppel, W.D. Merritt, and T.W. Keenan. Glycolipids as indicators of tumorigenesis. J. Supramol. Struct., 9:157–177, (1978).

    Article  PubMed  CAS  Google Scholar 

  14. J. Kawanami. Lipids of cancer tissue III. Glycolipids of human hepatoma tissue. Jap. J. Exp. Med., 38:11–18, (1968).

    PubMed  CAS  Google Scholar 

  15. Tanno Munehiko, et al. Copmparison of gangiosides pattern in cirrhotic liver and liver cell cancer. Liver, (Japan) 23:684, (1982).

    Google Scholar 

  16. Neng-hua Gho and Tian-Jue Gu. Ganglioside pattern in hepatoma. Acta. Acad. Med. Primae, Shangai, 12: 149–151, (1985).

    Google Scholar 

  17. Zheng-mei Zhu, De-sheng Zhang, Ji-ding Yuan, and Tian-jue Gu. The distribution pattern of ganglioside in normal, embryonic, and cancerous human liver. Acta. Acad. Med. Primae., Shangai, 18:234–236, (1983).

    Google Scholar 

  18. V.P. Walter, T.M. Kloppel, I.G. Deimling, and D.J. Morre. Alterations in neutral glycosphingolipids from transplantable hepatomas and in sera of rats bearing transplantable hepatomas. Cancer Biochem. Biophys., 4: 145–151, (1980).

    CAS  Google Scholar 

  19. T. Momoi, S. Ando, and Y. Magai. High resolution preparative column chromatographic system for ganglioside DEAE-Sephadex and a new porous silica, Iatrobeads. Biochim. Biophys. Acta, 441:448–497, (1976).

    Google Scholar 

  20. R.W. Ledeen and R.K. Yu. Gangliosides: structure, isolation, and analysis, in “Methods on Enzymology” V. Ginsberg ed., 83:139–191, (1982).

    Google Scholar 

  21. S. Hakomori. Tumor associated glycolipid antigens defined by monoclonal antibodies. Bull. Cancer, 70:118–126, (1983).

    PubMed  CAS  Google Scholar 

  22. Neng-hua Guo and Tian-Jue Gu. Ganglioside pattern in hepatocellular hepatoma. Acta Biochim. Biophys. Sinica, 17:538–543, (1985).

    CAS  Google Scholar 

  23. Xia-juan Xia, Zhao-chun Cui, and Tian-Jue Gu. Isolation and purification of the hepatoma associated ganglioside. Chinese Biochem J. 1(2):13–17, (1985).

    CAS  Google Scholar 

  24. Xia-juan Xia, Zhao-chun Cui, and Tian-Jue Gu. Composition and carbohydrate sequence analysis of the hepatoma associated ganglioside. Acta Biochim. Biophys. Sinica, 17:615–623, (1985).

    CAS  Google Scholar 

  25. Xia-juan Xia, De-sheng Zhang, Zhao-chun Cui, Lan-nian Zhang, and Tian-Jue Gu. Permethylation analysis of hepatoma associated ganglioside. Acta Biochim. Biophys. Sinica, 17:635–642, (1985).

    CAS  Google Scholar 

  26. M. Inbar and L. Sachs. Interaction of the carbohydrate- binding protein Concanavalin A with normal and transformed cells. Proc. Nat’1. Acad. Sci. USA, 63:1418–1425, (1969).

    Article  CAS  Google Scholar 

  27. L.D. Berman. Lack of correlation between growth characteristics, agglutinability by plant lectins and the malignant phenotype. Int. J. Cancer, 15: 973–979, (1975).

    Article  PubMed  CAS  Google Scholar 

  28. Zheng-Mei Zhu and Tian-Jue Gu. The agglutinative effect of Con A and PHA on normal, embryonic, and tumor cells. Chinese J. Cell Biol., 4(l):35–37, (1982).

    Google Scholar 

  29. Zheng-Mei Zhu and Tian-Jue Gu. The function of cell membrane in cell agglutination. Chinese J. Cell Biol. 4(2):16–19. (1982).

    CAS  Google Scholar 

  30. Zheng-Mei Zhu and Tian-Jue Gu. Con A receptors on normal liver and hepatoma cells. Chinese J. Cell Biol. 4(3): 21–24, (1982).

    CAS  Google Scholar 

  31. Zheng-Mei Zhu and Tian-Jue Gu. Agglutinin and cell agglutination IV characterization of Concanavalin A receptors on hepatoma cells. Acta Biochim. Biophys. Sinica, 14:295–301, (1982).

    CAS  Google Scholar 

  32. Xie-lin Ren, Jun-Cai Lin, and Tian-jue Gu. Comparison of soybean agglutinin receptors on hepatoma and normal mouse liver cells. Tumor, 2(5):4–6, (1982).

    Google Scholar 

  33. J.U. Baenziger and Y. Maynard. Human hepatic lectin purification. J. Biol. Chem., 225: 4 607–4613, (1980).

    Google Scholar 

  34. A G. Morell, G. Gregoriadis, and I.H. Scheinberg. The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem., 246:1461–1467, (1971).

    PubMed  CAS  Google Scholar 

  35. G. Uhlenbruck, J. Beuth, and V. Weidtman. Liver lectins: mediators for metastases? Experentia, 39: 1314–1315, (1983).

    Article  CAS  Google Scholar 

  36. S.H. Berondes. Lectins: their multiple endogenous cellular functions. Ann. Rev. Biochem., 50: 207–231, (1981).

    Article  Google Scholar 

  37. Hui-ren Zhou, Zheng-Mei Zhu and Tian-Jue Gu. B- galactoside specific lectins in normal anmd cancer bearing rat liver cells. Acta Acad. Med. Primae, Shangai, 11:361–364, (1984).

    CAS  Google Scholar 

  38. J.H. Jandel and J.H. Katz. The plasma-to-cell cyle of transferrin. J. Chin. Invest. 42:314–326, (1963).

    Article  Google Scholar 

  39. I.S. Trowbridge, R. A. Newman, and D.L. Domingo. Transferrin Receptors: structure and function. Biochem. Pharmcol., 33:925–932, (1984).

    Article  CAS  Google Scholar 

  40. W.P. Faulk and G.M.P. Galbraith. Trophoblast transferrin and transferrin receptor in the host parasite relationship of human pregnancy. Proc. Royal Soc. Lond. (Biol), 204:83–97, (1979).

    Article  CAS  Google Scholar 

  41. G.M. Galbraith, R.H. Galbraith, and W.P. Faulk. Transferrin binding by human lymphoblastoid cell lines and other transformed cells. Cell Immun., 49:215–222, (1980).

    Article  CAS  Google Scholar 

  42. R. Sutherland, D. Delia, C. Schneider, R. Newman, J. Kemshead, and M. Greaves. Ubiquitous cell surface glycoproteins on tumor cells is proliferation associated receptor for transferrin. Proc. Nat’1. Acad. Sci. USA, 78 4515–4519, (1981).

    Article  CAS  Google Scholar 

  43. D. Delia, M.F. Greaves, R. Newman. Modulation of Tleukemic cell phenotype with phorbol ester. Int. J. Cancer, Int. J. Cancer, 29; 23–31, (1982).

    CAS  Google Scholar 

  44. P. Reichard. From deoxynucleotides to DNA synthesis. Federation Proc., 37:9–14, (1978).

    CAS  Google Scholar 

  45. L. Vodinelich, R Sutherland, C. Schneider, R. Newman, and M. Greaves. Receptor for transferrin may be a target structure for natural killer cells. Proc. Natl. Acad Sci. USA, 80:835–839, (1983).

    Article  PubMed  CAS  Google Scholar 

  46. R. J. Stockert, A. G. Morell and I.H. Scheinberg. Hepatic binding protein: The protective role of its sialic acid residues. Science 197:66–68, (1977).

    Article  Google Scholar 

  47. Hui-ren Zhou, Jin-yu Ma, and Tian-Jue Gu. Detection of transferrin receptor on cancer cell mebrane and the preparation of transferrin receptor and its antibody. Acta. Acad Med. Primae Shangii 11:165, (1984).

    CAS  Google Scholar 

  48. Hui-ren Zhou, Jian-nan Yeh, and Tian-Jue Gu. The uptake of 125I-transferrin in N-nitrosurea induced rat mammary tumor. In press.

    Google Scholar 

  49. Yu-ding Kuo, Z.Y. Tang, Z.Y. Lin, Z.S. Ma, K.G. Cheng, and W.Y. Yhao. Observation of radioimmunodetection of 131I-anti AFP in nude mice bearing human hepatocellular carcinoma. Tumor, 51:4–6, (1985).

    Google Scholar 

  50. D. Yu and Z.Y. Tang. Radioscanning of hepatocellular cancer using 131I-anti-acid ferrin antibody. Thesis for M.S. degree, (1984).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Gu, TJ. (1988). Glycolipids and Glycoproteins in Plasma Membrane of Hepatocellular Cancer. In: Wu, A.M., Adams, L.G. (eds) The Molecular Immunology of Complex Carbohydrates. Advances in Experimental Medicine and Biology, vol 228. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1663-3_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1663-3_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8923-4

  • Online ISBN: 978-1-4613-1663-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics